Wegovy

Definition

Wegovy is a prescription medication containing semaglutide, used for chronic weight management in adults with obesity or overweight conditions. It works by mimicking the GLP-1 hormone to regulate appetite and caloric intake.

5 Must Know Facts For Your Next Test

1. Wegovy is administered via subcutaneous injection once a week.
2. It was approved by the FDA in June 2021 for chronic weight management.
3. Common side effects include nausea, vomiting, diarrhea, and constipation.
4. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC).
5. The medication functions as a GLP-1 receptor agonist to help control hunger and food intake.

Review Questions

• What is the active ingredient in Wegovy and how does it function?
• Describe the common side effects associated with Wegovy.
• For what specific condition is Wegovy contraindicated?

Related terms

GLP-1 Receptor Agonist: A class of drugs that mimic the action of the glucagon-like peptide-1 to help regulate blood sugar levels and appetite.

Medullary Thyroid Carcinoma (MTC): A type of thyroid cancer that Wegovy users should be screened for due to potential risks.

Obesity: A medical condition characterized by excess body fat that increases the risk of health problems, often treated with medications like Wegovy.